Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.
about
Ral GTPases in tumorigenesis: emerging from the shadowsSynthesis of novel Ral inhibitors: An in vitro and in vivo studyDiscovery and characterization of small molecules that target the GTPase RalTranslation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonizationUrothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data.An online tool for evaluating diagnostic and prognostic gene expression biomarkers in bladder cancerSuppression of SIPA-1 expression may reduce bladder cancer invasion and metastasis via the downregulation of E-cadherin and ZO-1.DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer.κB-Ras proteins regulate both NF-κB-dependent inflammation and Ral-dependent proliferation.RalA is overactivated in medulloblastoma.Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer.Understanding the biology of urothelial cancer metastasis.
P2860
Q28294053-6F6513D9-6F8D-42F9-89AC-D117BEE4DCBEQ28817036-0A5F929C-EDE2-4E26-95E7-0A741E9A355AQ30366783-E2BB1A6A-D16C-433D-AFB3-15FD9C9E0FAEQ30416020-D5DEA0DC-2374-4284-A711-57037DE6D073Q35630898-268B2403-6AEA-443A-AFC8-7CC43693AC26Q35678922-D1485886-9C55-495D-80A3-78C570BE59DBQ36502021-6726FC35-4C9F-4FA9-B9BF-7261886F7317Q36550104-488418FC-8EF2-4C36-B337-0735D7E4AAF1Q37536632-7B611552-96EC-45A6-9317-A3EA077970A5Q37603357-D79F9344-236F-408B-A1D2-FFE544B9C20FQ38306683-914290AC-6DE9-490A-872D-405743B0209DQ38956617-57E6B93C-3E36-46E4-A396-85F1B3CEDE8EQ39449209-1337AC8E-16F9-45DA-9927-31248FEA2290Q46080553-4E827843-E7BD-4777-BB38-1CEDFB5B4273Q47340259-7CBCA206-2110-4533-9E81-D213751FB258Q55126311-23EDC1F1-3C29-4977-B024-15680FF2F703
P2860
Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Transcriptional signatures of ...... aracteristics in human cancer.
@ast
Transcriptional signatures of ...... aracteristics in human cancer.
@en
type
label
Transcriptional signatures of ...... aracteristics in human cancer.
@ast
Transcriptional signatures of ...... aracteristics in human cancer.
@en
prefLabel
Transcriptional signatures of ...... aracteristics in human cancer.
@ast
Transcriptional signatures of ...... aracteristics in human cancer.
@en
P2093
P2860
P1433
P1476
Transcriptional signatures of ...... aracteristics in human cancer.
@en
P2093
Alexander S Baras
Charles R Owens
Dan Theodorescu
Garrett Dancik
Steven C Smith
P2860
P304
P356
10.1158/0008-5472.CAN-11-3966
P407
P577
2012-05-14T00:00:00Z